Navigation Links
Senetek PLC Announces New Investor Communication Hotline

NAPA, Calif., April 1 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today announced plans for the creation of a new communication hotline for the expressed purpose of keeping the investment community updated on key events. Bi-weekly updates will be recorded on a designated call-in number which is targeted to be up and running in early May. In addition, callers will be able to leave their contact information regarding any questions they may have.

The Company will periodically supplement the hotline with live investor teleconferences to announce and discuss significant material events. Frank J. Massino, Chairman and Chief Executive Officer stated, "that in today's volatile business and political environments, it is important to keep our shareholders updated in a timely manner on events shaping the Company."

About Senetek PLC:

Senetek PLC (OTCBB:SNKTY) is a Life Sciences company engaged in the development of breakthrough technologies that target the science of healthy aging. The company's extensive research collaborations have resulted in a strong pipeline of patented compounds and products with broad therapeutic applications and a leading presence in dermatology. Senetek collaborates with established specialty pharmaceutical companies in the final development and marketing of its proprietary products, most recently resulting in the development of kinetin, the best-selling anti-aging product sold in the North American physician market. For more information, visit the company's websites:

This news release contains statements that may be considered 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act. Forward-looking statements by their nature involve substantial uncertainty, and actual results may differ materially from those that might be suggested by such statements. Important factors identified by the Company that it believes could result in such material differences are described in the Company's Annual Report on Form 10-K for the year 2008. However, the Company necessarily can give no assurance that it has identified or will identify all of the factors that may result in any particular forward-looking statement materially differing from actual results, and the Company assumes no obligation to correct or update any forward-looking statements which may prove to be inaccurate, whether as a result of new information, future events or otherwise.

Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Senetek PLC Announces 2008 Annual General Meeting Voting Results
2. Senetek PLC Acquires Rights to Additional Anticancer RNAi Technology
3. Senetek Affirms Strong Financial Position
4. Senetek PLC Reports Second Quarter 2008 Financial Results
5. Senetek PLC Reports First Quarter 2008 Financial Results
6. Senetek PLC Announces Appointments of Key Personnel
7. Senetek PLC in Dispute With Marketer of Pyratine-6(TM)
8. NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results
9. ACM Global Central Lab Announces Partnership with Chindexs United Family Hospitals in China
10. Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India
11. ArunA Biomedical Announces Co-development of Fully Validated Induced Pluripotent Stem Cell Kit
Post Your Comments:
(Date:11/30/2015)... Nov. 30, 2015 Spherix Incorporated (Nasdaq: ... to the fostering and monetization of intellectual property, ... prospective initiatives designed to create shareholder value. ... of Spherix. "Based on published reports, the total ... $50 billion and Spherix will seek to secure ...
(Date:11/30/2015)... SAN DIEGO , Nov. 30, 2015  HUYA ... China,s pharmaceutical innovations, today announced ... Korea Drug Development Fund (KDDF) to foster collaboration between ... Korean development and commercialization of healthcare products for the ... potential as an important source of new innovative preclinical ...
(Date:11/30/2015)... San Jose, CA (PRWEB) , ... ... ... the Content Intelligence Company, today announced tighter software integration with MarkLogic, the ... management where organizations maximize information to drive change. , Smartlogic’s Content Intelligence ...
(Date:11/27/2015)... , November 27, 2015 ... Growing popularity of companion diagnostics is one ... biomarkers market with pharmaceutical companies and diagnostic ... diagnostic tests. . ... Complete report on global cancer biomarkers market ...
Breaking Biology Technology:
(Date:11/26/2015)... Research and Markets ( ) has announced the ... and Patent Infringement Risk Analysis" report to their ... Fingerprint sensors using capacitive technology represent a fast ... Idex forecasts an increase of 360% of the number ... the fingerprint sensor market between 2014 and 2017 (source ...
(Date:11/19/2015)... 2015  Based on its in-depth analysis of the ... with the 2015 Global Frost & Sullivan Award for ... presents this award to the company that has developed ... of the market it serves. The award recognizes the ... on customer base demands, the overall impact it has ...
(Date:11/18/2015)... , Nov. 18, 2015  As new scientific ... children, doctors and other healthcare providers face challenges in ... families and patients. In addition, as more children continue ... a patient,s adulthood and old age. John ... The Children,s Hospital of Philadelphia (CHOP) . ...
Breaking Biology News(10 mins):